[go: up one dir, main page]

DK0546038T3 - Indgiftsform til tidsvarierende mønstre for lægemiddelafgivelse - Google Patents

Indgiftsform til tidsvarierende mønstre for lægemiddelafgivelse

Info

Publication number
DK0546038T3
DK0546038T3 DK91915824.6T DK91915824T DK0546038T3 DK 0546038 T3 DK0546038 T3 DK 0546038T3 DK 91915824 T DK91915824 T DK 91915824T DK 0546038 T3 DK0546038 T3 DK 0546038T3
Authority
DK
Denmark
Prior art keywords
dosage form
administration
time
drug delivery
drug
Prior art date
Application number
DK91915824.6T
Other languages
Danish (da)
English (en)
Inventor
Felix Theeuwes
Patrick S-L Wong
Anthony L Kuczynski
Atul Devdatt Ayer
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24302741&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0546038(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DK0546038T3 publication Critical patent/DK0546038T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
  • Bus Control (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91915824.6T 1990-08-31 1991-08-28 Indgiftsform til tidsvarierende mønstre for lægemiddelafgivelse DK0546038T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/576,042 US5156850A (en) 1990-08-31 1990-08-31 Dosage form for time-varying patterns of drug delivery

Publications (1)

Publication Number Publication Date
DK0546038T3 true DK0546038T3 (da) 1994-11-28

Family

ID=24302741

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91915824.6T DK0546038T3 (da) 1990-08-31 1991-08-28 Indgiftsform til tidsvarierende mønstre for lægemiddelafgivelse

Country Status (18)

Country Link
US (2) US5156850A (fr)
EP (1) EP0546038B1 (fr)
JP (1) JP2796433B2 (fr)
KR (1) KR0162106B1 (fr)
AT (1) ATE108999T1 (fr)
AU (1) AU648822B2 (fr)
CA (1) CA2088376C (fr)
DE (1) DE69103153T2 (fr)
DK (1) DK0546038T3 (fr)
ES (1) ES2056660T3 (fr)
FI (1) FI107699B (fr)
IE (1) IE67163B1 (fr)
MX (1) MX9100838A (fr)
NO (1) NO304580B1 (fr)
NZ (1) NZ239574A (fr)
PT (1) PT98802B (fr)
WO (1) WO1992004011A1 (fr)
ZA (1) ZA916802B (fr)

Families Citing this family (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
US5422122A (en) * 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
RO112991B1 (ro) * 1992-09-18 1998-03-30 Yamanouchi Pharma Co Ltd Preparat tip hidrogel, cu eliberare sustinuta
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
PT946151E (pt) * 1996-11-25 2006-07-31 Alza Corp Forma de dosagem de dose crescente
EP1782798A3 (fr) 1996-11-25 2008-05-21 Alza Corporation Forme posologique à libération de dose croissante
US5788987A (en) 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
IT1291652B1 (it) * 1997-04-24 1999-01-19 Apr Trading Sa Composizioni farmaceutiche a copertura terapeutica programmata
US6962997B1 (en) * 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
DE19747261A1 (de) * 1997-10-25 1999-04-29 Bayer Ag Osmotisches Arzneimittelfreisetzungssystem
US8524277B2 (en) 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US5945123A (en) * 1998-04-02 1999-08-31 K-V Pharmaceutical Company Maximizing effectiveness of substances used to improve health and well being
KR100827254B1 (ko) * 1998-06-03 2008-05-07 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
JP2002521338A (ja) * 1998-07-21 2002-07-16 アルペンストック・ホールディングス・リミテッド 抗脂血症製剤
US6322819B1 (en) * 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
KR20070051953A (ko) 1998-11-02 2007-05-18 엘란 코포레이션, 피엘씨 다입자 변형 방출 조성물
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6387403B1 (en) 1999-09-15 2002-05-14 Alza Corporation Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
US6610674B1 (en) * 1999-09-28 2003-08-26 University Of Pennsylvania Method of treating inflammatory conditions with progesterone analogs
EP2269587A1 (fr) 1999-10-29 2011-01-05 Euro-Celtique S.A. Formulations d'hydrocodone à liberation lente
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
JP2003518487A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク ヒドロゲル駆動型積層薬物製剤
ATE392890T1 (de) * 1999-12-23 2008-05-15 Pfizer Prod Inc Hydrogel-gesteuerte dosierungsform
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US6733783B2 (en) 2000-10-30 2004-05-11 Euro-Celtique S.A. Controlled release hydrocodone formulations
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
IL159715A0 (en) * 2001-07-10 2004-06-20 Teva Pharma Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
WO2003051341A1 (fr) * 2001-12-18 2003-06-26 Alza Corporation Forme posologique permettant d'obtenir des modeles d'apport de medicaments variant dans le temps
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
NZ552514A (en) * 2001-12-24 2008-08-29 Teva Pharma Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
PL373031A1 (en) * 2002-04-29 2005-08-08 Alza Corporation Methods and dosage forms for controlled delivery of oxycodone
US20050106249A1 (en) * 2002-04-29 2005-05-19 Stephen Hwang Once-a-day, oral, controlled-release, oxycodone dosage forms
NZ536693A (en) * 2002-05-31 2007-01-26 Alza Corp Controlled release dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
US20040005359A1 (en) * 2002-06-27 2004-01-08 Cheng Xiu Xiu Controlled release oral dosage form
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US20050208132A1 (en) * 2002-07-29 2005-09-22 Gayatri Sathyan Methods and dosage forms for reducing side effects of benzisozazole derivatives
WO2004010970A1 (fr) * 2002-07-29 2004-02-05 Alza Corporation Formulations et formes posologiques pour une administration controlee de topiramate
AU2003256844A1 (en) * 2002-07-29 2004-02-16 Alza Corporation Methods and dosage forms for controlled delivery of paliperidone
CN100479818C (zh) * 2002-07-31 2009-04-22 化法公司 治疗内耳疾病的药物配方和其应用方法
US6913768B2 (en) * 2002-09-24 2005-07-05 Shire Laboratories, Inc. Sustained release delivery of amphetamine salts
CN101797221B (zh) 2002-12-13 2013-06-12 杜雷科特公司 包含高粘度液体载体材料的口服递药系统
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
US8293799B2 (en) * 2003-12-29 2012-10-23 Osmotica Keresleedelmo és Szolgáltató KFT Osmotic device containing a venlafaxine salt and a salt having an ion in common
US20040166160A1 (en) * 2003-01-14 2004-08-26 Ramkumar Subramanian Methods and dosage forms with modified viscosity layers
ATE401866T1 (de) * 2003-02-11 2008-08-15 Alza Corp Verfahren und dosierformen mit modifizierter schichtgeometrie
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
JP2007501248A (ja) * 2003-08-06 2007-01-25 アルザ・コーポレーシヨン 増進した分散調合物による長時間にわたるトピラメートの均一送達
AU2004268549A1 (en) * 2003-08-22 2005-03-10 Alza Corporation Stepwise delivery of topiramate over prolonged period of time
CA2564227A1 (fr) * 2003-09-02 2005-03-10 Alza Corporation Compositions medicamenteuses et formes pharmaceutiques de topiramate
JP2007506775A (ja) 2003-09-26 2007-03-22 アルザ・コーポレーシヨン 漸増する放出速度を表す制御放出製剤
CN102697704A (zh) * 2003-09-26 2012-10-03 阿尔扎公司 阿片类与非阿片类镇痛药的控释制剂
CA2540308C (fr) 2003-09-26 2013-08-06 Alza Corporation Enrobage de medicaments a charge medicamenteuse elevee et procedes de fabrication
AU2004275813A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Osmotic dosage forms for controlled delivery of alprazolam
US20050163850A1 (en) * 2003-10-31 2005-07-28 Wong Patrick S. Administration of levodopa and carbidopa
KR20060123493A (ko) * 2003-12-23 2006-12-01 알자 코포레이션 제어된 전달을 위한 약물 조성물의 용해도를 증가시키는방법 및 제형
US20050175696A1 (en) * 2003-12-29 2005-08-11 David Edgren Drug granule coatings that impart smear resistance during mechanical compression
JP2007517061A (ja) * 2003-12-29 2007-06-28 アルザ・コーポレーシヨン 新規薬剤組成物及び投与形態物
WO2005065648A2 (fr) * 2003-12-29 2005-07-21 Alza Corporation, Inc., Nouvelles preparations de medicaments et formes posologiques de topiramate
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
WO2006007323A2 (fr) * 2004-06-28 2006-01-19 Alza Corporation Formes posologiques pour agents pharmaceutiques exempts d'acides a taux de dissolution et/ou de solubilite bas
US8541026B2 (en) * 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
EP1830648A4 (fr) * 2004-12-09 2008-03-12 Celgene Corp Traitement au moyen de d-threo methylphenidate
DE602006003639D1 (de) * 2005-01-27 2008-12-24 Alza Corp Orale osmotische darreichungsform mit membran mit hoher flussdichte
EP1874269A2 (fr) * 2005-04-19 2008-01-09 Alza Corporation Combinaison de tramadol et de matieres renfermant la gabapentine
KR20080030637A (ko) * 2005-06-29 2008-04-04 알자 코포레이션 삼투성 제형에 대하여 감소된 건조 시간을 제공하는반투과성 조성물
WO2007106111A2 (fr) * 2005-07-01 2007-09-20 Elan Pharma International Limited Compositions nanoparticulaires et a liberation controlee comprenant de la nilvadipine
WO2007019393A2 (fr) * 2005-08-04 2007-02-15 Alza Corporation Formes posologiques osmotiques comprenant des membranes semi-permeables formees de melanges polymeres presentant des caracteristiques ameliorees
US8778395B2 (en) * 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
WO2007044234A1 (fr) * 2005-10-07 2007-04-19 Alza Corporation Forme posologique osmotique a aspects de liberation controlee et de liberation rapide
PL116330U1 (en) * 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
US20070196487A1 (en) * 2006-02-16 2007-08-23 Geerke Johan H Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
BRPI0709606B8 (pt) 2006-03-16 2021-05-25 Tris Pharma Inc suspensão líquida administrável oralmente com características de liberação modificada
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
EP2049089A4 (fr) * 2006-08-08 2012-07-04 Accu Break Technologies Inc Comprimé pharmaceutique contenant une pluralité de segments actifs
WO2008084698A1 (fr) 2006-12-28 2008-07-17 Astellas Pharma Inc. Composition pharmaceutique à libération entretenue de tacrolimus
US8524749B2 (en) * 2007-02-09 2013-09-03 Alza Corporation Controlled release compositions of tizanidine
EP2120945A1 (fr) * 2007-02-28 2009-11-25 Collegium Pharmaceutical, Inc. Combinaison d'antihistaminiques
AU2008335809A1 (en) 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
CN102316730A (zh) * 2008-05-09 2012-01-11 天雅瑞药业有限公司 用于减轻全身性炎症和/或血管炎症的n-乙酰半胱氨酸(nac)的控释
MX2011000909A (es) * 2008-07-30 2011-02-23 Panacea Biotec Ltd Composiciones de ramipril de liberacion modificada y usos de las mismas.
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
WO2010077925A2 (fr) 2008-12-16 2010-07-08 Teva Pharmaceutical Industries Ltd. Système d'administration médicamenteuse d'ordre zéro, administration médicamenteuse biphasique d'ordre zéro, ascendante ou descendante de méthylphénidate
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
JP5600174B2 (ja) * 2009-09-15 2014-10-01 チーム アカデミー オブ ファーマシューティカル サイエンス 浸透圧ポンプ型放出制御錠及びその製造方法
PL2554168T3 (pl) 2010-03-29 2018-05-30 Astellas Pharma Inc. Kompozycja farmaceutyczna do kontrolowanego uwalniania
CA2789307A1 (fr) * 2010-03-29 2011-10-06 Hetero Research Foundation Composition pharmaceutique stable d'imatinib
US8287903B2 (en) 2011-02-15 2012-10-16 Tris Pharma Inc Orally effective methylphenidate extended release powder and aqueous suspension product
US9862908B2 (en) * 2012-01-17 2018-01-09 Croda, Inc. Seal swell additive
DK2884961T3 (en) 2012-08-15 2019-04-23 Tris Pharma Inc METHYLPHENIDATE TABLE WITH EXTENDED RELEASE
CN105120659A (zh) 2013-03-15 2015-12-02 度瑞公司 用于降低溶解可变性的具有流变改性剂的组合物
CA2902911C (fr) 2014-10-31 2017-06-27 Purdue Pharma Methodes et compositions destinees au traitement du trouble de deficit d'attention
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
CN109475505A (zh) 2016-07-06 2019-03-15 度瑞公司 具有药物组成物、屏障层及药物层的口服剂型
US9707217B1 (en) 2017-02-03 2017-07-18 Osmotica Kereskedelmi Es Szolgaltato Kft Dose-dumping resistant controlled release dosage form
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
EP3752133A1 (fr) 2018-02-16 2020-12-23 Esperion Therapeutics, Inc. Formulations à libération prolongée d'acide bempedoique
ES2909803T3 (es) * 2018-03-05 2022-05-10 Amneal Complex Products Res Llc Composiciones farmacéuticas programables para la cronoliberación de fármacos
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
EP3934622A1 (fr) 2019-03-05 2022-01-12 Amneal Complex Products Research LLC Compositions de méthylphénidate à libération retardée
MX2022001865A (es) 2019-08-12 2022-03-11 Massachusetts Inst Technology Articulos y metodos para la administracion de agentes terapeuticos.
CN114681422B (zh) * 2020-12-30 2023-09-05 深圳翰宇药业股份有限公司 一种硝苯地平控释片及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4318400A (en) * 1980-01-18 1982-03-09 Alza Corporation Medical infusor
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4863744A (en) * 1984-09-17 1989-09-05 Alza Corporation Intestine drug delivery
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
US4950486A (en) * 1987-10-02 1990-08-21 Alza Corporation Dosage form for treating cardiovascular diseases
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
US4966769A (en) * 1988-06-02 1990-10-30 Alza Corporation Method for delivering dosage form for diltiazem
WO1990008536A1 (fr) * 1989-01-30 1990-08-09 Alza Corporation Forme de dosage pour administrer un antagoniste du calcium
HU205851B (en) * 1989-01-31 1992-07-28 Int Pharma Agentur Systhem of regulated release of the active components and process for producing it
US4984592A (en) * 1989-12-18 1991-01-15 Christine Hellein Manicure shield
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device

Also Published As

Publication number Publication date
JPH06500774A (ja) 1994-01-27
FI930862L (fi) 1993-02-25
NO930604D0 (no) 1993-02-22
PT98802B (pt) 1999-01-29
ES2056660T3 (es) 1994-10-01
FI930862A0 (fi) 1993-02-25
FI107699B (fi) 2001-09-28
AU648822B2 (en) 1994-05-05
ZA916802B (en) 1992-05-27
DE69103153T2 (de) 1994-11-24
NZ239574A (en) 1993-10-26
ATE108999T1 (de) 1994-08-15
DE69103153D1 (de) 1994-09-01
IE67163B1 (en) 1996-03-06
NO304580B1 (no) 1999-01-18
US5156850A (en) 1992-10-20
PT98802A (pt) 1993-12-31
US5785994A (en) 1998-07-28
JP2796433B2 (ja) 1998-09-10
EP0546038B1 (fr) 1994-07-27
KR0162106B1 (ko) 1998-12-01
IE913023A1 (en) 1992-03-11
EP0546038A1 (fr) 1993-06-16
MX9100838A (es) 1992-04-01
WO1992004011A1 (fr) 1992-03-19
CA2088376C (fr) 2001-05-01
CA2088376A1 (fr) 1992-03-01
NO930604L (no) 1993-02-26
KR930701156A (ko) 1993-06-11
AU8500091A (en) 1992-03-30

Similar Documents

Publication Publication Date Title
DK0546038T3 (da) Indgiftsform til tidsvarierende mønstre for lægemiddelafgivelse
SE8701900D0 (sv) Pulsed drug delivery
GR1002564B (el) Στερεα απο του στοματος χορηγουμενη φαρμακευτικη μορφη δοσιμετρησεως προγραμματισμενου ρυθμου απελευθερωσεως.
MX9203755A (es) Dispositivo de suministro iontoforetico de drogas o agentes terapeuticos, dotado de un adhesivo de electrotransporte.
DE69527509D1 (de) Hydrogelformulierung mit gesteuerter freisetzung
DK1035834T3 (da) Osmotisk doseringsform omfattende en første og anden coating
GEP20063773B (en) Steroid Sulphatase Inhibitors
ATE210474T1 (de) Implantierbare vorrichtung zur arzneiabgabe
ATE234602T1 (de) Verabreichungsform zur abgabe von steigenden wirkstoffdosen
ATE292453T1 (de) Antivirale arznei
HRP920834B1 (en) A method for producing an administration and/or dosage form for pharmaceutical active substances using a printing method
NO975140D0 (no) Transdermalt terapeutisk system (TTS) for administrasjon av testosteron
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
ES2187156T3 (es) Terapia antidepresiva.
NZ314488A (en) Anticancer medicaments containing alpha1-adrenoreceptor antagonist compounds
MY100780A (en) Azumolene dosage form.
GR3019608T3 (en) Peroral administration form for peptidic medicaments, in particular insulin.
ATE116845T1 (de) Dosierungsform zur verabreichung von arzneimitteln für die zirkadiantherapie.
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
RU97117735A (ru) Способ лечения дифтерии
MX9605190A (es) Forma de dosis efectiva para farmacos antiepilepticos.
NO931208L (no) Formuleringer for transdermale kontraseptiver, samt fremgangsmaater og innretninger for tilfoersel av slike